4DS MEMORY LIMITED — Director's Dealing 2016

Dec 18, 2016

Appendix 3Y Change of Director’s Interest Notice

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Introduced 30/9/2001.
Name of entity	4DS Memory Limited
ABN	43 145 590 110

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Mr David McAuliffe
Date of last notice	15 July 2016

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest		Direct and Indirect
Nature of indirect interest(including registered holder)Note: Provide details of the circumstancesgiving rise to the relevant interest.		Concept Biotech Pty Ltd (director related entity)David Jerimiah McAuliffe (trustee and beneficiary)
Date of change		19 December 2016
No. of securities held prior tochange		DirectDavid McAuliffe700,000 fully paid Ordinary Shares840,825 fully paid Ordinary Shares escrowed until 17/12/2017156,763 Class 1 Performance Shares escrowed until 17/12/2017IndirectConcept Biotech Pty Ltd2,498,812 fully paid Ordinary Shares escrowed until 17/12/2017David Jerimiah McAuliffe7,501,188 fully paid Ordinary Shares escrowed until 17/12/2017
Class		Fully paid ordinary shares escrowed until 17/12/2017
Number acquired		156,763 fully paid ordinary shares escrowed until 17/12/2017
Number disposed		156,763 conversion of Class 1 Performance Shares escroweduntil 17/12/2017

• See chapter 19 for defined terms.

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Value/Considerationincludes brokerage/gstNote: If consideration is non-cash, providedetails and estimated valuation		Not applicable
No. of securities held afterchange		DirectDavid McAuliffe700,000 fully paid Ordinary Shares997,588 fully paid Ordinary Shares escrowed until 17/12/2017IndirectConcept Biotech Pty Ltd2,498,812 fully paid Ordinary Shares escrowed until 17/12/2017David Jerimiah McAuliffe7,501,188 fully paid Ordinary Shares escrowed until 17/12/2017
Nature of changeExample: on-market trade, off-market trade,exercise of options, issue of securities underdividend reinvestment plan, participation inbuy-back		Issued pursuant to conversion of Class 1 performance shares ona one for one basis due to the milestones being met.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

sclosed in thispart.
Detail of contract	N/A
Nature of interest	N/A
Name of registered holder(if issued securities)	N/A
Date of change	N/A
No. and class of securities to whichinterest related prior to changeNote: Details are only required for a contract in relationto which the interest has changed	N/A
Interest acquired	N/A
Interest disposed	N/A
Value/ConsiderationNote: If consideration is non-cash, provide details and anestimated valuation	N/A
Interest after change	N/A

Part 3 –[+] Closed period

art 3 –+Closed period
Were the interests in the securities or contracts detailed abovetraded during a+closed period where prior written clearance**was required? **	No
If so, was prior written clearance provided to allow the trade toproceed during this period?	N/A
If prior written clearance was provided, on what date was thisprovided?	N/A

• See chapter 19 for defined terms.

Appendix 3Y Page 2